MedTech Spectrum

Article Name Europe

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients across U.K.

This innovative test, originally developed by Memorial Sloan Kettering Cancer Centre in New York

13th May, 2026

Roche Receives CE Mark for New Blood Test to Detect Alzheimer's Pathology

The launch of pTau217 marks a significant step in providing a simple, blood-based tool to diagnose Alzheimer's much earlier in the patient journey

13th May, 2026

Bindex Brings Osteoporosis Screening to Boots Pharmacies

The collaboration helps raise awareness of personal osteoporosis risk earlier and encourages proactive steps before fractures occur

12th May, 2026

Scantox Upgrades DuplexSeq Bioinformatics with Cloud-Based Mutagenesis App

Scantox completes DuplexSeq technology transition, advancing error-corrected sequencing on a scalable cloud-based platform.

12th May, 2026

Imaging and Precision Therapy Drive Siemens Healthineers Q2 Growth

The medtech major delivered overall comparable revenue growth of 3.1 per cent during the quarter

08th May, 2026

Microsure Secures CE Mark for MUSA-3 as Surgical Robotics Firm Moves Into Clinical Growth Phase

The approval allows Microsure to begin clinical use of its MUSA-3 microsurgical robotics system in Europe, while the appointment of Alex Joseph as CEO signals a shift from product development toward evidence generation, hospital adoption, and commercial execution.

07th May, 2026

FutureLife Becomes First European Fertility Network to Adopt an End-to-End AI Fertility Platform

Network-wide partnership with Alife Health brings a comprehensive AI platform for fertility care, including CE-marked Embryo Predict, to clinics across 16 countries

06th May, 2026

Ribbon Bio Launches Cell-Free MiroSynth DNA and New In-Lab Cell-Free DNA Production Kit

Together, these announcements represent a step forward in increasing accessibility to complex DNA

06th May, 2026

CorTec GmbH Demonstrates Thought-Controlled Computer Use with Implanted BCI

The same fully implanted, wireless device supporting motor recovery after stroke now enables thought-controlled computer use without additional surgery or hardware

30th April, 2026

Philips Launches New Bridge Plus Occlusion Balloon

Bridge Plus enables electrophysiology teams to respond in minutes – helping stabilise patients and buy critical time for surgical repair

24th April, 2026

Senseonics Announces European Launch of Eversense 365

Eversense 365 is now available to the first patients in Sweden, with launches to follow in Germany, Spain, and Italy during the coming weeks

24th April, 2026

Datasea Completes $1.01M AI Multimodal Projects to Advance High-Margin Digital Solutions Strategy

Delivery of three projects highlights growing adoption of AI-driven, scenario-based applications across enterprise and digital services

21st April, 2026

Bracco Secures Health Canada Approval for Vueway® to Advance Lower-Dose MRI Contrast Imaging

Gadopiclenol-based contrast agent enables high-quality imaging at reduced gadolinium exposure, supporting safer diagnostic workflows

20th April, 2026

FertilAI Secures CE Mark for Predictive AI in Fertility Treatment Optimisation

AI will soon enable clinicians to predict ovulation and optimize IVF cycle timing, improving outcomes and operational efficiency.

16th April, 2026

Cepheid And Oxford Nanopore Expand Partnership To Advance Rapid Genomic Workflow For Sepsis Research

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research

15th April, 2026

OSE Immunotherapeutics to Present First-in-Class FPR2 Agonist Antibody Data at AAI 2026

Novel monoclonal antibody targets resolution of chronic inflammation through a differentiated therapeutic strategy

15th April, 2026

Invivoscribe Elevates Molecular Diagnostics With PrepQuant System To Standardise And Accelerate Sample Preparation

Integrated automated platform unifies multi step sample preparation to improve consistency, reduce operational complexity, and enable high precision workflows across MRD testing and advanced molecular diagnostics

15th April, 2026